Efficacy and Tolerability of Pantovigar® Vegan in Female Subjects With Diffuse Hair Loss

Merz Pharmaceuticals

Status: Completed

Conditions: Diffuse Hair Loss in Females

Treatments: Dietary Supplement: Pantovigar® vegan

Study type: Interventional

Funder types: Industry

Identifiers

NCT05943860

M900411001

Details and patient eligibility

About

The objective of this study is to assess the hair growth efficacy of a Food for Special Medicinal Purposes (FSMP) Pantovigar® vegan after 3 and 6 months of intake.

Enrollment: 39 patients

Sex: Female

Ages: 30 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diffuse hair loss
• Modified Savin Score I to III
• Hair length of at least 2 cm

Exclusion criteria

• Pathological hair loss (like alopecia areata, universalis or totalis; scarring alopecias; androgenic alopecia; inflammatory conditions of the scalp)
• Symptomatic diffuse alopecia due to pathological low iron concentration or thyroid gland disorder
• Acute telogen effluvium
• Recent or concomitant treatment with any drugs that may cause hair loss
• Concomitant diseases that can cause hair loss

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

39 participants in 1 patient group

Pantovigar vegan treatment

Experimental group

Treatment:

Dietary Supplement: Pantovigar® vegan